Demonising Justin Gatlin
13th September 2015
The Fédération Internationale de Natation (FINA) has decided to issue Kylie Palmer with a reprimand, after the Court of Arbitration for Sport (CAS) upheld a World Anti-Doping Agency (WADA) appeal against an earlier decision not to bring forward an anti-doping rule violation (ADRV) against the Australian. Palmer (pictured) withdrew from the 2015 FINA World Championships this summer, voluntarily accepting a provisional suspension after FINA notified her and Swimming Australia of a 2013 positive test for ‘low levels’ of furosemide.
FINA had initially decided that no action should be taken against Palmer, however this year, WADA decided to appeal to the CAS against FINA’s decision not to bring forward an ADRV against Palmer. The CAS ruling ordered FINA to bring forward the findings as an ADRV, which is why Palmer and Swimming Australia were only alerted to the 2013 positive on 13 April 2015.
‘On 31st July 2013, the swimmer Kylie Palmer (AUS) was tested positive to the substance Furosemide (Class S.5 Diuretics and Masking Agents) with the occasion of the FINA World Championships-Barcelona 2013’, read a FINA statement issued today. ‘The FINA Doping Panel decided according to the FINA DC Rule 10.2.1 to give to the swimmer a warning and a reprimand. Furthermore, the FINA Doping Panel decided that all results achieved by the athlete on 31st July 2013 shall be annulled together with the consequences thereof (forfeiture of medals/prizes, reimbursement of prize money)’.
Palmer took gold with the Australian 4x200m women’s relay team at the Beijing 2008 Olympics and silver at the London 2012 Olympics, and is preparing to compete in the Rio 2016 Olympic Games. You can read more about the history of her case by clicking here.
• The decisions focused on enhanced Code compliance monitoring and increased budget; and also, on...
The Foundation Board of the World Anti-Doping Agency (WADA) has decided that the Russian Anti-Doping...